Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

CytoDyn Inc_INT buy geldnutzer

CytoDyn Inc_INT
Start price
€2.26
04.11.20 / 50%
Target price
€3.20
04.11.21
Performance (%)
-43.45%
End price
€1.28
10.07.21
Summary
This prediction ended on 10.07.21 with a price of €1.28. Massive losses of -43.45% were the result for the BUY prediction by geldnutzer. geldnutzer has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y 3y
CytoDyn Inc_INT - - - -
iShares Core DAX® 2.594% -1.861% 13.242% 16.867%
iShares Nasdaq 100 3.553% -2.064% 38.293% 45.898%
iShares Nikkei 225® 0.687% -8.704% 17.510% 2.760%
iShares S&P 500 2.209% -1.988% 27.632% 42.955%

According to geldnutzer what are the pros and cons of CytoDyn Inc_INT for the foreseeable future?

Pros
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Standard Investments for future growth
Valuable balance sheet
Capable Management
Good culture
Innovative
Differentiated customer and product portfolio
Very Future proof/growth oriented business model
Cons
Significant cyclical dependencies
High valuation
Very low/no dividend yield expected
negative Cash Flow expected
Bad rating
ROE lower than 10% per year
Increased challenges to pay loans and raise capital
Growths slower than the competition
Sustainability is little important
high free float
Higher risks for its business
Below average Marketposition
Little known brand

Comments by geldnutzer for this prediction

In the thread CytoDyn Inc diskutieren
Prediction Buy
Perf. (%) -43.45%
Target price 3.000
Change
Ends at 04.11.21

Buy mit Kursziel 3,0

geldnutzer 
0
Report Share
04.11.20
Prediction Buy
Perf. (%) -43.45%
Target price 5.000
Change
Ends at 04.11.21

Kursziel geändert auf 5,0

geldnutzer 
0
Report Share
21.12.20
Prediction Buy
Perf. (%) -43.45%
Target price 5.200
Change
Ends at 04.11.21

Kursziel geändert auf 5,2

geldnutzer 
0
Report Share
22.12.20
Prediction Buy
Perf. (%) -43.45%
Target price 3.200
Change
Ends at 04.11.21

Kursziel geändert auf 3,2

geldnutzer 
0
Report Share
19.04.21
In the thread Trading CytoDyn Inc
Prediction Sell
Perf. (%) -43.45%
Target price 3.200
Change
Ends at 04.11.21

Buy beendet

geldnutzer 
0
Report Share
10.07.21

Stopped prediction by geldnutzer for CytoDyn Inc_INT

sell
CytoDyn Inc_INT

Start price
Target price
Perf. (%)
€0.29
02.03.23
€0.10
02.03.24
-25.70%
03.03.24

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Significant cyclical dependencies
geldnutzer 
02.03.23 50%
buy
CytoDyn Inc_INT

Start price
Target price
Perf. (%)
€0.33
27.02.23
€0.50
27.02.24
-10.72%
02.03.23

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Significant cyclical dependencies
geldnutzer 
27.02.23 50%
sell
CytoDyn Inc_INT

Start price
Target price
Perf. (%)
€0.34
19.11.22
€0.10
19.11.23
-5.60%
27.02.23

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Significant cyclical dependencies
geldnutzer 
19.11.22 50%
buy
CytoDyn Inc_INT

Start price
Target price
Perf. (%)
€0.65
21.07.22
€0.60
21.07.23
-46.97%
19.11.22

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Significant cyclical dependencies
geldnutzer 
21.07.22 50%
sell
CytoDyn Inc_INT

Start price
Target price
Perf. (%)
€0.66
09.01.22
€0.20
09.01.23
-1.09%
21.07.22

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Significant cyclical dependencies
geldnutzer 
09.01.22 50%
buy
CytoDyn Inc_INT

Start price
Target price
Perf. (%)
€0.88
20.12.21
€1.20
20.12.22
-25.64%
09.01.22

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Significant cyclical dependencies
geldnutzer 
20.12.21 50%
sell
CytoDyn Inc_INT

Start price
Target price
Perf. (%)
€1.28
10.07.21
€0.80
10.07.22
-30.80%
20.12.21

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Significant cyclical dependencies
geldnutzer 
10.07.21 50%
sell
CytoDyn Inc_INT

Start price
Target price
Perf. (%)
€2.10
23.10.20
€1.00
04.11.21
7.62%
04.11.20

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Significant cyclical dependencies
geldnutzer 
23.10.20 50%